Vivos Therapeutics, Inc. SEC filings VVOS

Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Vivos Therapeutics, Inc. SEC filings
Form Description Filed Period
10-K Annual report Apr 15, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
10-K/A Amended annual report Jul 30, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
VVOS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Littleton, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716166
Former names
Vivos BioTechnologies, Inc. (until Sep 29, 2017)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.